Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acinox is a multi-ingredient nutritional supplement developed and marketed by San Fegan Biotech Pvt Ltd, a pharmaceutical company based in India. Formulated as an oral tablet, it contains a combination of antioxidants and essential nutrients, including beta-carotene, sodium selenate (selenium), methionine, N-acetylcysteine, vitamin E, vitamin C, and zinc sulphate monohydrate. Primarily indicated for gastroenterology applications, Acinox is used to provide antioxidant support, boost immunity, and maintain normal physiological mechanisms in patients suffering from long-term illnesses. It is marketed to help overcome weakness, stress, exhaustion, and extreme tiredness while supporting the body's ability to fight infections and prevent disease. The product is currently available as a commercialized pharmaceutical supplement in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Acinox.